Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

CYTORI THERAPEUTICS INC (CYTX)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
Sales 2018 10,2 M
EBIT 2018 -11,7 M
Net income 2018 -11,7 M
Debt 2018 -
Yield 2018 -
Sales 2019 22,7 M
EBIT 2019 -2,06 M
Net income 2019 -2,86 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 1,68x
Capi. / Sales2019 0,76x
Capitalization 17,2 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical... 
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
05/23CYTORI THERAPEUTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in ..
AQ
05/23Cytori Therapeutic’s common stock to begin trading on adjusted basis on..
GL
05/18CYTORI THERAPEUTICS, INC. : Change in Directors or Principal Officers, Submissio..
AQ
05/17CYTORI THERAPEUTICS : Reports Q1 2018 Business and Financial Results
AQ
05/11CYTORI THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
AQ
05/11CYTORI THERAPEUTICS : Reports Q1 2018 Business and Financial Results
AQ
05/11CYTORI : 1Q Earnings Snapshot
AQ
05/10CYTORI THERAPEUTICS, INC. : Results of Operations and Financial Condition, Finan..
AQ
05/10Cytori Reports Q1 2018 Business and Financial Results
GL
05/07Cytori to Webcast First Quarter Financial Results on May 10
GL
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
05/16Zoetis to buy veterinary diagnostics firm Abaxis for $1.9 billion
RE
05/16Sivantos and Widex in $8 billion merger to create No.3 in hearing aids
RE
05/10Shares of Medical Technology Companies Down After Hours on New Study--Market ..
DJ
05/10HEART DEVICE PROCEDURE IS NO BETTER : Study
DJ
05/08WILLIAM DEMANT A/S : shares plummet after growth outlook fails to impress
RE
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2016Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2016 Results - Earnings Ca.. 
2016Cytori Therapeutics EPS in-line, beats on revenue 
2016Cytori Cell Therapy an Orphan Drug in Europe for scleroderma-related hand dys.. 
2016Notable earnings after Tuesday?s close 
2016Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co.. 
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 1,78 $
Spread / Average Target 537%
EPS Revisions
Managers
NameTitle
Marc H. Hedrick President, Chief Executive Officer & Director
Richard J. Hawkins Chairman
Tiago Girão CFO & Principal Accounting Officer
John K. Fraser Chief Scientist
Mark T. Marino Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CYTORI THERAPEUTICS INC-4.14%17
MEDTRONIC PLC5.40%115 166
BAXTER INTERNATIONAL11.54%38 405
ALIGN TECHNOLOGY, INC.11.20%23 873
ZIMMER BIOMET HOLDINGS-6.40%22 959
TERUMO CORP18.59%22 168